Phillip Alexander Keller Andersen

Phillip Alexander Keller Andersen serves as a Guest Researcher in the Department of Biomedical Sciences within the Faculty of Health and Medical Sciences at the University of Copenhagen. His research focuses on pancreatic beta cell biology in diabetes contexts, specifically examining circadian rhythms, inflammatory pathways, and proteasome function. His work bridges molecular endocrinology and immunometabolism with clinical diabetes research.

Andersen's primary research interests center on circadian biology in pancreatic islets, cytokine-mediated beta cell dysfunction, and proteasome regulation in diabetes pathogenesis. His investigations reveal how inflammatory stressors disrupt circadian clocks in beta cells, leading to uncoordinated gene expression and cell death. Key discoveries include the role of immunoproteasomes in proinsulin degradation and the differential effects of cytokines on circadian remodeling in diabetic models.

Analysis of his five publications (2019-2025) shows consistent focus on beta cell circadian disruption as a nexus between inflammation and diabetes progression. His work integrates transcriptomics, proteomics, and functional assays to demonstrate how nitric oxide, lysine deacetylases, and immunoproteasomes mediate cytokine effects on islet clocks. Recent 2025 research extends these findings to transcriptomic remodeling and cell death mechanisms.

Andersen collaborates extensively with leading diabetes researchers including Mandrup-Poulsen, Dibner, and Dahlby, evidenced by multi-author publications in high-impact journals. His work appears in iScience, International Journal of Molecular Sciences, and Diabetologia, with significant attention on social platforms (32+ social media mentions) and academic networks (143+ Mendeley readers).

His laboratory work occurs within the Inflammation, Metabolism and Oxidation research group at Blegdamsvej 3B, Copenhagen. Current projects investigate circadian synchronization strategies to protect beta cells from inflammatory damage, with potential therapeutic applications for diabetes prevention.